SINOFILINGS / BUSINESS LIBRARY600176 / PUBLISHED
Annual business review / fy2020-financial-close-20261005

China Jushi FY2020: Products and glass-fiber technology

Products, applications, research and commercial progress.

Evidence-linked English operating research. The source and stated coverage below define the scope of this version. Source-page links provide optional verification; the English account is intended to stand on its own.

Reporting period ended 2020-12-31 / Filing published 2021-03-20
Content version 14 / b5e2dfea68bb / PUBLISHED

Products and applications

Additional product certifications

The company reports obtaining additional certifications from the American Bureau of Shipping, Saudi Arabia's SABER system and the United Kingdom's WRAS water-contact scheme. The same discussion describes raw-material and chemical testing under a new supplier-management system. These disclosures explain qualification and quality-control work. They do not identify each certified product grade, certification number or a sales contract arising from certification.

Different fiber applications, different commercialization evidence

The report places glass fiber in construction materials, electrical and electronic products, transport, pipes and tanks, industrial applications and renewable-energy equipment. Wind applications include blades and nacelles, while automotive applications use fiber-reinforced thermoplastic or thermoset composites. In electronics, glass yarn is woven into fabric used in copper-clad laminates, which in turn form the base for printed circuit boards. These are downstream uses of the company’s material, not proof that it supplies a named vehicle manufacturer, turbine project or electronics device. Roving and related products are reported in tonnes, whereas electronic fabric is reported in metres; those volumes cannot be added. The existing annual production and sales figures remain separate from installed design capacity and project ignition dates. The ABS, Saudi SABER and UK WRAS qualifications described elsewhere support potential access to particular applications or markets, but the report does not provide grade-specific revenue, customer orders or certificate specifications for each. Industry application shares and market forecasts are not substituted for Jushi’s own sales mix.

Technology and commercial progress

Research spending and a China–Egypt laboratory initiative

R&D investment was RMB 341,662,980.95, entirely expensed, 2.93% of revenue; research personnel numbered 1,766. The company obtained 98 patent authorisations, including 48 inventions. A China–Egypt high-performance glass fiber and composites joint laboratory received a Ministry of Science and Technology assistance-project approval. Approval of the laboratory initiative and patent outcomes are distinguished from commercial product deliveries.

Research addresses the production system as well as products

Research covered glass formulations, sizing chemicals, fiber products, composite applications, machinery, cleaner production and intelligent manufacturing. Sizing and formulation are disclosed research areas; the report does not give enough grade-level specifications or independent performance tests to establish a universal technical advantage. FY2020 R&D expenditure was CNY 341,662,980.95, equal to 2.93% of revenue, and was entirely expensed: capitalized R&D was zero. The 1,766 research personnel represented 15.07% of employees. The report also describes patent grants and approval of assistance for a China–Egypt joint laboratory, already recorded separately; patents and an approved laboratory initiative are not commercial shipments. Reported material cost was CNY 2,406,124,579.58, up 19.96%. The table’s 31.15% cost share is consistent with total consolidated operating cost, not the narrower fiber-cost row; it is not presented here as the material share of fiber-only cost. The disclosure does not allocate research or material spending to individual production lines, or quantify savings achieved by each technical initiative.

Research expenditure / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
RMB 341,662,980.95
Capitalized research expenditure / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
RMB 0
Research personnel / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
1,766 persons
Reported material cost / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
RMB 2,406,124,579.58

Read the complete annual research snapshot

Sources and scope

What this guide establishes

  • FY2020 business, management, shareholder/governance and financial important-content selection is complete under editorial-selection-v1. Routine accounting classifications and non-material administration are condensed with original evidence retained. This is not full transcription or independent editorial approval. Source inconsistencies and unexplained bridges remain explicit. Commercial source-use basis and independent editorial review remain pending.
  • Tonnes, fabric metres, nameplate capacity, ignition dates and actual annual output remain distinct. Product and regional tables are overlapping main-business views. Anonymous rankings and clearing-company entries do not identify underlying counterparties.
  • Guarantee activity and closing balances, treasury new placements and mixed-period principal lists, proposed distributions and actual cash, shareholder pledges and issuer debt, and actual pollutant quantities versus standard concentration limits retain separate scopes.
  • Original currencies and precision are retained. Minority transfer, consolidation, profit and cash settlement differ. Chengdu line ignition and base-level completion are different stages. Proposed integration failed; the subsequent extension is not an acquisition. No counterparty research is extended.
  • Industry forecasts and leadership claims are attributed or condensed. Inconsistent industry-output totals remain unresolved and omitted from verified company results. Historical trade/tax information does not establish current legal rates.
  • Tax bases are specific to named subjects and historical eligibility. Aggregate other-receivable allowance movements reconcile, but the printed stage-column presentation remains unexplained; blank debtor allowances do not establish zero risk. Endorsed or discounted bills, derecognition and cash receipts differ. US trial-product estimated sale value is not sales revenue or realized cash.
  • Construction budget, engineering progress, cumulative investment, closing construction and fixed-asset transfers are different measures. Selected programme names are retained without inventing project identities or adding component capacity again. Mining-rights impairment is not automatically the same asset as Juhong environmental-boundary impairment. Title application and goodwill valuation do not establish operating permission or absence of risk.
  • Debt balances and issuance/cash flows have separate scopes. Retained-bill labels conflict; subsidy cash, grant basic amounts and recognized income differ. US trial-product sale amounts occur in the expense table. Aggregate cash adjustments are not trade-only changes, and the depreciation bridge is unexplained.
  • Full subsidiary and associate results, minority allocations and parent-only accounts have different scopes. Egypt transaction equity adjustments retain an unexplained difference. The Lifan plan allocations reconcile after correction of an earlier English misreading. Closing ownership cannot allocate all annual earnings automatically, and plan recovery is not completed recovery.
  • Original page163 specifies400000CNY planned Lifan cash, not4400000. The plan total reconciles. Earlier incorrect English and snapshots are retained but rejected for current use; actual recovery remains separate from the approved plan.
  • Revenue recognition follows customer control, not cash receipt. Other products within main business differ from other-business revenue; one operating segment does not supply separate regional profit accounts. Tax cash, expenses and balances, and long-lived-asset payments, investment transactions and financing flows retain distinct scopes.
  • Land, energy and other intangible carrying values do not certify plant permits or additional output. Functional selling/admin expenses differ from supplier transactions and cash payments; unspecified line-item causes and plant allocations are not invented.
FY2020 full annual report ↗
Chinese / A-share / Chinese Accounting Standards / Published 2021-03-20
PDF SHA-256: cbba64c59d36a001fa9b73e9e150f68b414bd6c2f8a3ccbc4e075ab91628813d